National Hospital Organization Yokohama Medical Center

Kanagawa, Yokohama 245-8575

0 studies enrolling now · 4 studies all time

What they study most

Diabetes Mellitus, Type 2, Hypertension, Portal, Liver Diseases, Non-alcoholic Steatohepatitis (NASH)

Studies at this site

• A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) — Stopped early
• A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) — Stopped early
• A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3) — Completed
• Linagliptin as Add on to Basal Insulin in the Elderly — Completed